Casma: Casma Therapeutics Appoints Nagesh Mahanthappa, Ph.D., MBA, to Board of Directors

(marketscreener.com) Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced the appointment of Nagesh Mahanthappa, Ph.D., MBA, to its Board of Directors. "We are pleased to welcome Nagesh to our Board of Directors at this significant next stage of Casma's development," stated...https://www.marketscreener.com/news/latest/Casma-Therapeutics-Appoints-Nagesh-Mahanthappa-Ph-D-MBA-to-Board-of-Directors--31801145/?utm_medium=RSS&utm_content=20201117